carbamates has been researched along with Regurgitation, Gastric in 1 studies
Regurgitation, Gastric: GASTROESOPHAGEAL REFLUX wherein the retrograde flow passes through the UPPER ESOPHAGEAL SPHINCTER
| Excerpt | Relevance | Reference |
|---|---|---|
| " A mouse model of laryngopharyngeal reflux (mechanical laryngeal injury once weekly for 2 weeks and pH 7 solvent/pepsin instillation 3 days/week for 4 weeks) was provided inhibitor by gavage or aerosol (fosamprenavir or darunavir; 5 days/week for 4 weeks; n = 3)." | 8.31 | Oral and Inhaled Fosamprenavir Reverses Pepsin-Induced Damage in a Laryngopharyngeal Reflux Mouse Model. ( Arnold, LA; Blumin, JH; Bock, J; Goetz, CJ; Johnston, N; MacKinnon, AC; Miller, J; Ondrey, F; Samuels, TL; Seabloom, D; Silvaggi, NR; Smith, BC; Vuksanovic, N; Wiedmann, TS; Wuertz, B, 2023) |
| " A mouse model of laryngopharyngeal reflux (mechanical laryngeal injury once weekly for 2 weeks and pH 7 solvent/pepsin instillation 3 days/week for 4 weeks) was provided inhibitor by gavage or aerosol (fosamprenavir or darunavir; 5 days/week for 4 weeks; n = 3)." | 4.31 | Oral and Inhaled Fosamprenavir Reverses Pepsin-Induced Damage in a Laryngopharyngeal Reflux Mouse Model. ( Arnold, LA; Blumin, JH; Bock, J; Goetz, CJ; Johnston, N; MacKinnon, AC; Miller, J; Ondrey, F; Samuels, TL; Seabloom, D; Silvaggi, NR; Smith, BC; Vuksanovic, N; Wiedmann, TS; Wuertz, B, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnston, N | 1 |
| Samuels, TL | 1 |
| Goetz, CJ | 1 |
| Arnold, LA | 1 |
| Smith, BC | 1 |
| Seabloom, D | 1 |
| Wuertz, B | 1 |
| Ondrey, F | 1 |
| Wiedmann, TS | 1 |
| Vuksanovic, N | 1 |
| Silvaggi, NR | 1 |
| MacKinnon, AC | 1 |
| Miller, J | 1 |
| Bock, J | 1 |
| Blumin, JH | 1 |
1 other study available for carbamates and Regurgitation, Gastric
| Article | Year |
|---|---|
Oral and Inhaled Fosamprenavir Reverses Pepsin-Induced Damage in a Laryngopharyngeal Reflux Mouse Model.
Topics: Animals; Carbamates; Furans; Laryngopharyngeal Reflux; Larynx; Mice; Pepsin A; Sulfonamides | 2023 |